Role of Prophylactic Oral Antibiotics in the Prevention of Post-cataract Surgery Acute Infective Endophthalmitis

Overview

Journal Cureus

Specialty Biomedical Engineering

Date 2023 Aug 30

PMID 37644955

Authors

Aruba Zafar

Fiza Shaheen

Tahira Afzal

Sabihuddin Ahmad

Muhammad Amjad

Affiliations

Soon will be listed here.

Abstract

Purpose To evaluate the role of perioperative oral antibiotics in the prevention of acute infective endophthalmitis (IE) after cataract surgery. Methods A prospective cohort study of patients older than 18 years of age undergoing uncomplicated phacoemulsification was conducted. Group A was given post-op oral ciprofloxacin for three days, whereas Group B was not. Both groups received 5% povidone-iodine (PVI) preparation for five minutes in the conjunctival cul-de-sac, and intracameral (IC) 0.5% moxifloxacin was administered at the end of the procedure as prophylaxis. The minimum post-op follow-up period was six weeks. Results Out of 2161 patients, 859 (39.8%) were included in Group A, and 1302 (60.2%) were included in Group B. No significant difference in anterior chamber (AC) reaction was found on day 1 (p = 0.67), day 14 (p = 0.03), or day 45 (p = 0.1). One patient developed acute post-op IE (0.04%) and two patients developed toxic anterior segment syndrome (TASS) from Group A. The non-oral antibiotic group had no serious complications. Conclusion Perioperative oral antibiotic use in routine clinical practice is not recommended for the prevention of acute post-op IE. Pre-op conjunctival PVI 5% for five minutes and IC moxifloxacin at the end of surgery were proven to be effective prophylactic measures in our study.

References

Althiabi S, Aljbreen A, Alshutily A, Althwiny F . Postoperative Endophthalmitis After Cataract Surgery: An Update. Cureus. 2022; 14(2):e22003. PMC: 8913541. DOI: 10.7759/cureus.22003. View

Jabs D, Nussenblatt R, Rosenbaum J . Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol. 2005; 140(3):509-16. PMC: 8935739. DOI: 10.1016/j.ajo.2005.03.057. View

Laxminarayan R, Duse A, Wattal C, Zaidi A, Wertheim H, Sumpradit N . Antibiotic resistance-the need for global solutions. Lancet Infect Dis. 2013; 13(12):1057-98. DOI: 10.1016/S1473-3099(13)70318-9. View

Garg P, Roy A, Sharma S . Endophthalmitis after cataract surgery: epidemiology, risk factors, and evidence on protection. Curr Opin Ophthalmol. 2016; 28(1):67-72. DOI: 10.1097/ICU.0000000000000326. View

Lam P, Young A, Cheng L, Tam P, Lee V . Randomized controlled trial on the safety of intracameral cephalosporins in cataract surgery. Clin Ophthalmol. 2010; 4:1499-504. PMC: 3009998. DOI: 10.2147/OPTH.S15602. View

Ou J, Ta C . Endophthalmitis prophylaxis. Ophthalmol Clin North Am. 2006; 19(4):449-56. DOI: 10.1016/j.ohc.2006.07.005. View

Ciulla T, Starr M, Masket S . Bacterial endophthalmitis prophylaxis for cataract surgery: an evidence-based update. Ophthalmology. 2002; 109(1):13-24. DOI: 10.1016/s0161-6420(01)00899-5. View

Rosha D, Ng J, Morlet N, Boekelaar M, Wilson S, Hendrie D . Cataract surgery practice and endophthalmitis prevention by Australian and New Zealand ophthalmologists. Clin Exp Ophthalmol. 2006; 34(6):535-44. DOI: 10.1111/j.1442-9071.2006.01276.x. View

Matsuo T, Iguchi M, Morisato N, Murasako T, Hagiya H . Are Prophylactic Systemic Antibiotics Required in Patients with Cataract Surgery at Local Anesthesia?. Int J Environ Res Public Health. 2022; 19(23). PMC: 9740497. DOI: 10.3390/ijerph192315796. View

10.

Lopez-Cabezas C, Muner D, Massa M, Mensa Pueyo J . Antibiotics in endophthalmitis: microbiological and pharmacokinetic considerations. Curr Clin Pharmacol. 2010; 5(1):47-54. DOI: 10.2174/157488410790410597. View

11.

Hariprasad S, Shah G, Mieler W, Feiner L, Blinder K, Holekamp N . Vitreous and aqueous penetration of orally administered moxifloxacin in humans. Arch Ophthalmol. 2006; 124(2):178-82. DOI: 10.1001/archopht.124.2.178. View

12.

Jensen M, Fiscella R, Moshirfar M, Mooney B . Third- and fourth-generation fluoroquinolones: retrospective comparison of endophthalmitis after cataract surgery performed over 10 years. J Cataract Refract Surg. 2008; 34(9):1460-7. DOI: 10.1016/j.jcrs.2008.05.045. View

13.

Forster R . The endophthalmitis vitrectomy study. Arch Ophthalmol. 1995; 113(12):1555-7. DOI: 10.1001/archopht.1995.01100120085015. View

14.

Wu P, Li M, Chang S, Teng M, Yow S, Shin S . Risk of endophthalmitis after cataract surgery using different protocols for povidone- iodine preoperative disinfection. J Ocul Pharmacol Ther. 2006; 22(1):54-61. DOI: 10.1089/jop.2006.22.54. View

15.

Haripriya A, Chang D, Ravindran R . Endophthalmitis Reduction with Intracameral Moxifloxacin Prophylaxis: Analysis of 600 000 Surgeries. Ophthalmology. 2017; 124(6):768-775. DOI: 10.1016/j.ophtha.2017.01.026. View

16.

Speaker M, Menikoff J . Prophylaxis of endophthalmitis with topical povidone-iodine. Ophthalmology. 1991; 98(12):1769-75. DOI: 10.1016/s0161-6420(91)32052-9. View

17.

. Prophylaxis of postoperative endophthalmitis following cataract surgery: results of the ESCRS multicenter study and identification of risk factors. J Cataract Refract Surg. 2007; 33(6):978-88. DOI: 10.1016/j.jcrs.2007.02.032. View

18.

Herbert E, Pearce I, McGalliard J, Wong D, Groenewald C . Vitreous penetration of levofloxacin in the uninflamed phakic human eye. Br J Ophthalmol. 2002; 86(4):387-9. PMC: 1771086. DOI: 10.1136/bjo.86.4.387. View

19.

Davies J, Davies D . Origins and evolution of antibiotic resistance. Microbiol Mol Biol Rev. 2010; 74(3):417-33. PMC: 2937522. DOI: 10.1128/MMBR.00016-10. View

20.

Baig R, Mal P, Ahmed K, Sadiq S, Zafar S, Jabeen G . Microbial profile and antibiotic susceptibility trend in postoperative endophthalmitis: a 12-year review. J Pak Med Assoc. 2019; 69(11):1647-1650. DOI: 10.5455/JPMA.1902.. View